GHRP-2 (5mg)

$20.00

GHRP-2 (5mg) is offered by Biotech Peptides for laboratory and analytical research. Also known as Pralmorelin, GHRP-2 is a synthetic six-amino-acid peptide investigated in growth hormone secretagogue and appetite-regulation research.pubmed.ncbi.nlm.nih+1

  • Product: GHRP-2

  • Alternative name: Pralmorelin

  • Listed quantity: 5 mg

  • Reference sequence: H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂

  • Intended use: Laboratory and analytical research only

Review the manufacturer specifications and applicable analytical documentation before selecting material for your laboratory.

For research use only. Not for human consumption.

SKU: GHRP-2-5mg Category:
Description

GHRP-2 (5mg) for Laboratory Research

GHRP-2 (5mg) is offered by Biotech Peptides for laboratories investigating growth hormone secretagogues. Commonly known as Pralmorelin, GHRP-2 is a synthetic hexapeptide containing six amino-acid residues, including a nonstandard naphthylalanine residue.

For laboratories looking to buy GHRP-2, this listing identifies a 5 mg quantity. Assess the exact chemical form, structural specifications, and supporting analytical evidence against your protocol’s requirements before purchase.

Explore our research peptides for sale to review other laboratory-use listings from Biotech Peptides.

GHRP-2 Product Information

Property Listing information
Product name GHRP-2
Alternative name Pralmorelin
Listed quantity 5 mg
Intended application Laboratory and analytical research
Documentation inquiries Include the product name and batch identifier, where available

The 5 mg designation is the quantity stated for this listing. It does not independently establish net peptide content or confirm that a particular quantity-assay method has been performed.

Pralmorelin Reference Specifications

The following characteristics describe the Pralmorelin reference structure. Confirm the supplied chemical form and any counterions against manufacturer documentation before using reference values in analytical calculations.

Reference characteristic Information
Peptide length Six amino acids
Reference sequence H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂
Molecular formula, neutral reference structure C₄₅H₅₅N₉O₆
Approximate molecular weight 818.0 g/mol
PubChem compound identifier 6918245

These reference characteristics are documented in the PubChem Pralmorelin record. They do not verify the composition, purity, or quantity of an individual commercial batch.

In the sequence, D-2-Nal denotes D-2-naphthylalanine, while NH₂ identifies the C-terminal amide. The complete sequence is more informative than an abbreviated one-letter representation because it preserves the nonstandard residue and stereochemical details.

GHRP-2 and Growth Hormone Secretagogue Research

GHRP-2 is studied as an agonist of the growth hormone secretagogue receptor, commonly called the ghrelin receptor. Its research relevance includes both growth hormone secretion and feeding-related responses, rather than a single isolated endocrine effect.pubmed.ncbi.nlm.nih+1

Activation of this receptor system should not be interpreted as proof of muscle development, improved recovery, immune rejuvenation, or other health outcomes. Studies must be evaluated according to their model, duration, measurements, and limitations.

Human Appetite Research

A 2005 study compared GHRP-2 with saline in seven lean, healthy men. Researchers observed increased food intake during a freely available meal and an accompanying growth hormone response. This was a small, acute human experiment—not an animal study and not evidence of long-term clinical benefit.

Read the primary study of GHRP-2 and food intake in healthy men for the study design and results.

A subsequent study involving lean and obese participants also reported increased food intake under the tested conditions. The findings support the compound’s use in investigating ghrelin-associated feeding responses, but do not establish its suitability for personal appetite manipulation or treatment.

Read the study of GHRP-2 responses in lean and obese participants for further experimental context.

Published observations apply to the material and conditions evaluated by the investigators. They do not establish the biological activity of the product batch supplied with this listing.

Evidence Limitations and Safety Context

The FDA identifies potential immunogenicity concerns for compounded GHRP-2 preparations intended for injectable or nasal administration, including risks associated with aggregation and peptide-related impurities. It also notes that the unnatural amino-acid component adds complexity to substance characterization.

The agency reports serious adverse events in patients who received GHRP-2, including increased insulin requirements, infection, pancreatitis, and deaths among critically ill study participants. The FDA explicitly states that causality has not been established.

Review the FDA safety information concerning GHRP-2 when assessing the broader research evidence.

These limitations are important when distinguishing experimental findings from claims of human safety or therapeutic effectiveness.

Documentation and Batch Verification

Before selecting GHRP-2 (5mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:

  • Product name and batch or lot identifier.

  • Manufacturer specifications and chemical form.

  • Complete sequence, stereochemistry, and terminal groups.

  • Counterion information, where applicable.

  • Identity-testing methods and reported results.

  • Purity-testing methods and supporting analytical data.

  • Quantity or peptide-content measurements, where required.

  • Product-specific storage and handling instructions.

Match identifiers across the label, manufacturer specifications, and analytical reports. Resolve missing or inconsistent information before selecting the material.

For documentation inquiries, provide “GHRP-2 (5mg),” the batch number where available, and the specific information your laboratory requires.

Storage and Handling

Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.

Do not assume that storage temperatures, shelf-life claims, or preparation instructions for another supplier’s material apply to this product. Obtain clarification if documented instructions are unavailable or unclear.

Frequently Asked Questions About GHRP-2 (5mg)

Are GHRP-2 and Pralmorelin the same compound?

Pralmorelin is an accepted name for GHRP-2. Confirm the chemical form and structural specifications when comparing listings or analytical reports.

Is GHRP-2 a pentapeptide?

No. The reference sequence contains six amino-acid residues, making GHRP-2 a hexapeptide.

Is GHRP-2 the same as GHRP-6?

No. They are different compounds with different sequences. Their shared classification as growth hormone secretagogues does not make their analytical specifications interchangeable.pubchem.ncbi.nlm.nih+1

Does the 5mg designation describe a concentration?

No. It states the listed mass quantity. A concentration requires additional information, such as a defined volume.

Does published research confirm this product’s purity?

No. Scientific publications describe the experimental material used by the investigators. A commercial batch requires its own relevant specifications and analytical evidence.

Where can I find delivery information?

Review our shipping information for current order-processing and delivery terms.

Research Use Only

GHRP-2 (5mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.

Review our Research-Use-Only Policy before ordering.

Additional information
BrandBiotech Peptides
Shipping & Delivery